Oncology

< Back

Overview

The Oncology research area is composed by nine groups addressing the principal unsolved issues in cancer. Their research covers fields such as child and adolescent cancer, melanoma, Gynecology, Urology, cancer stem cells and the molecular mechanisms of the tumor pathologies.

There are also three groups from the CIBBIM-Nanomedicine. These groups study the use of nanotechnology in biomedical applications to improve therapeutic strategies and diagnostics.

Publications

125
total
725.353
impact factor
5.803
average impact factor

Group Leader: Eva Baldrich Rubio

group-team team group-zoom zoom group-download download

Research Areas

Our team was accepted in 2018 as a Consolidated Group by AGAUR. We incorporated in 2018 a new member, Kevin Arias, from Costa Rica, who obtained a prestigious INPhINIT predoctoral fellowship founded by La Caixa, which will support his research in the development of point-of-care diagnostic devices. Ana Sánchez Cano has been also granted an i-PFIS fellowship by Carlos III Institute. Over her PhD, she will produce a synthetic reagent to replace erythrocytes in the haemagglutination assays used worldwide to track the annual flu epidemics, a work she will carry out in collaboration with the company Pragmatic Diagnostics. The DTS17/00145 project has begun, in which we collaborate with the Microbiology Service and the Infectious Diseases Group to develop a Point-of-care diagnostic device for the fast and simple detection of malaria. The results produced allowed the group to publish in 2018 four articles in D1 journals, all of them with members of the team signing as the first author.

VHIR Annual Report 2018

© FIR-HUVH Fundació Institut de Recerca Hospital Universitari Vall d’Hebron 2019 | Developed by: ondeuev